» Authors » Benjamin A Dahl

Benjamin A Dahl

Explore the profile of Benjamin A Dahl including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 405
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Darwar R, Huang X, Abayeneh A, Alemayehu Beshah S, Patel M, Zeleke E, et al.
Vaccine . 2025 Feb; 50:126776. PMID: 39965299
Introduction: There is limited information about vaccine-preventable disease (VPD) surveillance cost. To address this gap, retrospective micro-costing studies of pre-COVID-19 pandemic VPD surveillance were conducted in Nepal and Ethiopia. Based...
2.
Hassan M, Basher A, Rahman M, Bhuiyan T, Chowdhury F, Hossain M, et al.
PLoS One . 2024 Dec; 19(12):e0316121. PMID: 39739828
Background: To optimize vaccination strategies, it is useful to detect breakthrough infections and assess vaccine effectiveness in programmatic use. Monitoring emerging SARS-CoV-2 variants and vaccine effectiveness against them is also...
3.
Doshi R, Nsasiirwe S, Dahlke M, Atagbaza A, Aluta O, Tatsinkou A, et al.
MMWR Morb Mortal Wkly Rep . 2024 Apr; 73(14):307-311. PMID: 38602879
With the availability of authorized COVID-19 vaccines in early 2021, vaccination became an effective tool to reduce COVID-19-associated morbidity and mortality. Initially, the World Health Organization (WHO) set an ambitious...
4.
Dahl B, Tritter B, Butryn D, Dahlke M, Browning S, Gelting R, et al.
Vaccine . 2024 Mar; 42 Suppl 3:125827. PMID: 38523004
In December 2021 the U.S. Government announced a new, whole-of-government $1.8 billion effort, the Initiative for Global Vaccine Access (Global VAX) in response to the global COVID-19 pandemic. Using the...
5.
Casey R, Nguna J, Opar B, Ampaire I, Lubwama J, Tanifum P, et al.
Int J Epidemiol . 2023 Feb; 52(4):1150-1162. PMID: 36762894
Background: Despite providing tetanus-toxoid-containing vaccine (TTCV) to infants and reproductive-age women, Uganda reports one of the highest incidences of non-neonatal tetanus (non-NT). Prompted by unusual epidemiologic trends among reported non-NT...
6.
Bigouette J, Callaghan A, Donadel M, Montesanti Porter A, Rosencrans L, Lickness J, et al.
Emerg Infect Dis . 2022 Dec; 28(13):S203-S207. PMID: 36502406
Global emergence of the COVID-19 pandemic in 2020 curtailed vaccine-preventable disease (VPD) surveillance activities, but little is known about which surveillance components were most affected. In May 2021, we surveyed...
7.
Donadel M, Scobie H, Pastore R, Grabovac V, Batmunkh N, OConnor S, et al.
Glob Health Sci Pract . 2022 Oct; 10(5). PMID: 36316133
Introduction: A strategic framework for 2021-2030 developed by the World Health Organization (WHO) Regional Office for the Western Pacific emphasizes the need for high-quality and integrated vaccine-preventable disease (VPD) surveillance....
8.
Tappero J, Cassell C, Bunnell R, Angulo F, Craig A, Pesik N, et al.
Emerg Infect Dis . 2017 Nov; 23(13). PMID: 29155656
To achieve compliance with the revised World Health Organization International Health Regulations (IHR 2005), countries must be able to rapidly prevent, detect, and respond to public health threats. Most nations,...
9.
Wassilak S, Williams C, Murrill C, Dahl B, Ohuabunwo C, Tangermann R
J Infect Dis . 2017 Aug; 216(suppl_1):S293-S298. PMID: 28838175
Surveillance for acute flaccid paralysis (AFP) is a fundamental cornerstone of the global polio eradication initiative (GPEI). Active surveillance (with visits to health facilities) is a critical strategy of AFP...
10.
Sissoko D, Keita M, Diallo B, Aliabadi N, Fitter D, Dahl B, et al.
Clin Infect Dis . 2016 Dec; 64(4):513-516. PMID: 27940938
A 9-month-old infant died from Ebola virus (EBOV) disease with unknown epidemiological link. While her parents did not report previous illness, laboratory investigations revealed persisting EBOV RNA in the mother's...